BCAM
Boston Common Asset Management Portfolio holdings
AUM
$3.57B
This Quarter Return
+6.48%
1 Year Return
+9.51%
3 Year Return
+37.41%
5 Year Return
+74.1%
10 Year Return
+185.14%
AUM
$3.57B
AUM Growth
+$3.57B
(+8.3%)
Cap. Flow
-$22M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
15.41%
Holding
326
New
35
Increased
82
Reduced
163
Closed
28
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$13.3M |
| 2 |
TSMC
TSM
|
$11.3M |
| 3 |
Salesforce
CRM
|
$9.79M |
| 4 |
KLA
KLAC
|
$9.44M |
| 5 |
Eli Lilly
LLY
|
$6.6M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$17.3M |
| 2 |
Hologic
HOLX
|
$16.8M |
| 3 |
Micron Technology
MU
|
$13.2M |
| 4 |
Ball Corp
BALL
|
$7.03M |
| 5 |
Zimmer Biomet
ZBH
|
$6.83M |
Sector Composition
| 1 | Technology | 13.67% |
| 2 | Financials | 8.72% |
| 3 | Healthcare | 5.07% |
| 4 | Communication Services | 4.95% |
| 5 | Industrials | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$368B
| $20.3M | 0.57% |
127,284
-34,040
| -21% | -$5.42M |
|
27
Vertiv
VRT
$48.7B
| $19.6M | 0.55% |
152,952
-20,814
| -12% | -$2.67M |
|
28
Carrier Global
CARR
$55.5B
| $18.7M | 0.53% |
256,127
-32,142
| -11% | -$2.35M |
|
29
Intuit
INTU
$186B
| $18.5M | 0.52% |
23,471
-599
| -2% | -$472K |
|
30
Danaher
DHR
$147B
| $17.4M | 0.49% |
87,844
-2,973
| -3% | -$587K |
|
31
Novartis
NVS
$245B
| $16.8M | 0.47% |
138,583
-11,877
| -8% | -$1.44M |
|
32
Emerson Electric
EMR
$74.3B
| $16.4M | 0.46% |
122,805
-33,241
| -21% | -$4.43M |
|
33
Xylem
XYL
$34.5B
| $16.2M | 0.45% |
125,029
-2,328
| -2% | -$301K |
|
34
SAP
SAP
$317B
| $15.3M | 0.43% |
50,300
-3,634
| -7% | -$1.11M |
|
35
Mercado Libre
MELI
$125B
| $15.3M | 0.43% |
5,837
+1,171
| +25% | +$3.06M |
|
36
Ecolab
ECL
$78.6B
| $14.7M | 0.41% |
54,382
-2,044
| -4% | -$551K |
|
37
MetLife
MET
$54.1B
| $14.3M | 0.4% |
177,887
-39,706
| -18% | -$3.19M |
|
38
CME Group
CME
$96B
| $13.7M | 0.38% |
49,598
+17,222
| +53% | +$4.75M |
|
39
Digital Realty Trust
DLR
$57.2B
| $13.6M | 0.38% |
78,242
+13,014
| +20% | +$2.27M |
|
40
Costco
COST
$418B
| $13.5M | 0.38% |
13,676
-488
| -3% | -$483K |
|
41
Gilead Sciences
GILD
$140B
| $13.5M | 0.38% |
122,085
-11,043
| -8% | -$1.22M |
|
|
42
Quest Diagnostics
DGX
$20.3B
| $13.3M | 0.37% |
+74,250
| New | +$13.3M |
|
43
Amgen
AMGN
$155B
| $13.3M | 0.37% |
47,460
-2,255
| -5% | -$630K |
|
44
Unilever
UL
$155B
| $13.1M | 0.37% |
214,160
+3,784
| +2% | +$231K |
|
|
SW
45
Smurfit Westrock plc
SW
$24.7B
| $13M | 0.36% |
300,134
-92,501
| -24% | -$3.99M |
|
46
Fifth Third Bancorp
FITB
$30.3B
| $12.5M | 0.35% |
303,355
+7,398
| +2% | +$304K |
|
47
Aon
AON
$79.1B
| $12.4M | 0.35% |
34,833
+8,394
| +32% | +$2.99M |
|
48
Bank of America
BAC
$376B
| $12.3M | 0.34% |
259,680
+24,740
| +11% | +$1.17M |
|
|
DAI
49
DELISTED
DAIMLER AG
DAI
| $12.3M | 0.34% |
210,357
-14,147
| -6% | -$825K |
|
50
Edwards Lifesciences
EW
$47.8B
| $11.8M | 0.33% |
150,862
+15,550
| +11% | +$1.22M |
|